Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.

This new technology could one day significantly expand the market for gene-editing biotechs.

The company's innovative qualities may pay rich dividends down the road.

Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...

Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

Researchers are investigating the potential of CRISPR in relation to Down syndrome.

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high cholesterol to a rare muscular disorder ...

A novel prime editing tool has unraveled some of the mysteries of fungi and identified compounds with promising anti-cancer ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...